Aventus Health introduces test for SARS-CoV-2 variant detection
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Aventus Health introduces test for SARS-CoV-2 variant detection  

15 Jun 2021 (Last Updated June 15th, 2021 10:03)

The test results can be used to study, track and understand emerging Covid-19 variants.

Aventus Health introduces test for SARS-CoV-2 variant detection  
The COVID-19 Variant Test can be used to precisely detect known and new SARS-CoV-2 variants. Credit: Testalize.me on Unsplash.

Aventus Health has introduced a new test, named COVID-19 Variant Test, to precisely detect known SARS-CoV-2 variants as well as identify new variants.

The test was created by integrating the company’s next-generation sequencing (NGS) technology with a lab-made assay that jointly breaks down the sequence of base pairs forming the genetic structure of the different SARS-CoV-2 strains.

This testing approach offers results that can be used to study, monitor and understand Covid-19 variants and their effect on public health.

Apart from the variant test, Aventus has a suite of Covid-19 testing services.

The company will now incorporate reflex testing to NGS into all of its reverse transcription-polymerase chain reaction (RT-PCR) patient tests that deliver a positive result in a bid to detect known and emerging variants.

Aventus CEO Oliver Dawoud said: “At the onset of the pandemic, Aventus released one of the most accurate Covid-19 RT-PCR tests in the market and went on to make Covid-19 testing widely available through our partnerships.

“To complete our wide array of services, we were able to utilise our state-of-the-art technology to bring to market SARS-CoV-2 variant testing. This is a breakthrough in healthcare that will greatly aid the general public in better understanding the different strains of Covid-19.”

Aventus medical director Michelle Taylor added that variant testing is complex as it needs genomic sequencing processes, which involve expensive technology and diagnostic capabilities.

Taylor added: “The instruments Aventus uses are manufactured for the highest sensitivity genetic sequencing capabilities on the market.

“They are critical to our mission of helping healthcare providers leverage innovations in genomics and diagnostics to deliver affordable and effective personalised and precision medicine.”

The Aventus Health portfolio includes integrated healthcare service companies and clinical care facilities.

It offers a platform for a variety of cost-effective and advanced solutions, including laboratory diagnostics, specialised pharmacies and interventional experts.